Annual Accounts Payable
$9.62 M
-$1.04 M-9.73%
December 31, 2024
Summary
- As of February 24, 2025, BBIO annual accounts payable is $9.62 million, with the most recent change of -$1.04 million (-9.73%) on December 31, 2024.
- During the last 3 years, BBIO annual accounts payable has fallen by -$2.27 million (-19.07%).
- BBIO annual accounts payable is now -28.80% below its all-time high of $13.51 million, reached on December 31, 2018.
Performance
BBIO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$9.62 M
-$3.75 M-28.03%
December 31, 2024
Summary
- As of February 24, 2025, BBIO quarterly accounts payable is $9.62 million, with the most recent change of -$3.75 million (-28.03%) on December 31, 2024.
- Over the past year, BBIO quarterly accounts payable has dropped by -$3.75 million (-28.03%).
- BBIO quarterly accounts payable is now -56.93% below its all-time high of $22.33 million, reached on June 30, 2021.
Performance
BBIO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
BBIO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.7% | -28.0% |
| 3 y3 years | -19.1% | -28.0% |
| 5 y5 years | +8.7% | -28.0% |
BBIO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.1% | at low | -46.9% | +148.3% |
| 5 y | 5-year | -19.1% | +8.7% | -56.9% | +148.3% |
| alltime | all time | -28.8% | +410.2% | -56.9% | +148.3% |
BridgeBio Pharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $9.62 M(-9.7%) | $9.62 M(-28.0%) |
| Sep 2024 | - | $13.36 M(-26.3%) |
| Jun 2024 | - | $18.13 M(+283.4%) |
| Mar 2024 | - | $4.73 M(-55.6%) |
| Dec 2023 | $10.65 M(-7.8%) | $10.65 M(+138.3%) |
| Sep 2023 | - | $4.47 M(+15.4%) |
| Jun 2023 | - | $3.87 M(-5.0%) |
| Mar 2023 | - | $4.08 M(-64.7%) |
| Dec 2022 | $11.56 M(-2.7%) | $11.56 M(+13.8%) |
| Sep 2022 | - | $10.16 M(+15.5%) |
| Jun 2022 | - | $8.79 M(-13.0%) |
| Mar 2022 | - | $10.11 M(-15.0%) |
| Dec 2021 | $11.88 M | $11.88 M(-1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $12.04 M(-46.1%) |
| Jun 2021 | - | $22.33 M(+115.9%) |
| Mar 2021 | - | $10.34 M(+15.6%) |
| Dec 2020 | $8.95 M(+1.1%) | $8.95 M(-9.1%) |
| Sep 2020 | - | $9.84 M(-23.3%) |
| Jun 2020 | - | $12.84 M(-1.9%) |
| Mar 2020 | - | $13.09 M(+47.8%) |
| Dec 2019 | $8.85 M(-34.5%) | $8.85 M(-13.8%) |
| Sep 2019 | - | $10.27 M(-36.1%) |
| Jun 2019 | - | $16.07 M(+30.1%) |
| Mar 2019 | - | $12.34 M(-8.6%) |
| Dec 2018 | $13.51 M(+616.7%) | $13.51 M |
| Dec 2017 | $1.89 M | - |
FAQ
- What is BridgeBio Pharma annual accounts payable?
- What is the all time high annual accounts payable for BridgeBio Pharma?
- What is BridgeBio Pharma annual accounts payable year-on-year change?
- What is BridgeBio Pharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly accounts payable year-on-year change?
What is BridgeBio Pharma annual accounts payable?
The current annual accounts payable of BBIO is $9.62 M
What is the all time high annual accounts payable for BridgeBio Pharma?
BridgeBio Pharma all-time high annual accounts payable is $13.51 M
What is BridgeBio Pharma annual accounts payable year-on-year change?
Over the past year, BBIO annual accounts payable has changed by -$1.04 M (-9.73%)
What is BridgeBio Pharma quarterly accounts payable?
The current quarterly accounts payable of BBIO is $9.62 M
What is the all time high quarterly accounts payable for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly accounts payable is $22.33 M
What is BridgeBio Pharma quarterly accounts payable year-on-year change?
Over the past year, BBIO quarterly accounts payable has changed by -$3.75 M (-28.03%)